A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study

BACKGROUND: Platelet (PLT) transfusion was the most practical way to increase patients’ PLT counts before invasive hepatic procedures such as radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). A novel drug that raises the PLT count by acting on the thrombopoietin receptor has recently...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Hideo, Ohki, Takamasa, Kanezaki, Mineo, Teratani, Takuma, Sato, Shinpei, Obi, Shuntaro, Sato, Takahisa, Akamatsu, Masatoshi, Uchino, Koji, Taniguchi, Hiroyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364390/
https://www.ncbi.nlm.nih.gov/pubmed/37488476
http://dx.doi.org/10.1186/s12876-023-02879-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364390/
https://www.ncbi.nlm.nih.gov/pubmed/37488476
http://dx.doi.org/10.1186/s12876-023-02879-0

Ejemplares similares